Sustainable Meaningful Access to Theranostic Care - Bridging the Gap Between Clinical and Computational Nuclear Oncology

Explore the intersection of clinical practice and computational approaches in nuclear oncology through this 40-minute invited lecture by Dr. Babak Saboury, Senior Clinical Advisor at NIH and President of the Institute of Nuclear Medicine. Examine the Fourth Industrial Revolution's impact on theranostic care and understand why radiopharmaceutical therapy (RPT) represents a unique treatment modality distinct from both conventional pharmacotherapy and radiation therapy. Analyze the fundamental differences between chemistry and physics approaches in nuclear medicine, and discover seven grand challenges that must be overcome to transition from mere availability to true accessibility of theranostic treatments. Learn about personalized RPT planning methodologies and the emerging concept of theranostic digital twins for patient-specific treatment optimization. Investigate the integration of clinical and computational nuclear oncology practices, including the critical need for universal ontology and radiopharmaceutical data standardization through initiatives like NucLex. Understand the pathway from treatment availability to sustainable meaningful access, addressing healthcare equity and implementation challenges in nuclear medicine. Gain insights into how computational tools and artificial intelligence can enhance clinical decision-making in theranostic applications, ultimately improving patient outcomes in nuclear oncology practice.